Join us in building the future of precision medicine
Philip Low, PhD and Chris Leamon, PhD, biochemists at Purdue University, were the first to discover a mechanism to exploit the folate receptors as a means to deliver bioactive molecules inside cells. Their discovery is revolutionizing precision medicine with the potential to treat many diseases that affect many people.
Our management is currently guiding several drugs through clinical trials, while supporting the development of additional applications. Our commitment to improving the lives of patients is paramount to everything we do and is the spirit behind our vision and values.
See our career opportunities for openings at our offices in Purdue Research Park, West Lafayette, Indiana, and in Indianapolis, Indiana; Europe; and other locations as we expand our operations.
Endocyte is an equal opportunity employer
Endocyte is committed to equal employment opportunity. We strive to find ways to attract, develop, and retain highly qualified individuals who represent the diverse communities in which we live and work. Applicants are invited to request reasonable accommodation to participate in the application process, if necessary.